Latest filing published 13 Aug 2026 for Theralase Technologies Inc., €164k.
Kaouthar Lbiati appears in our data through filings on Theralase Technologies Inc. shares, published by SEDI. In total, 6 filings cover trades dated from 24 May 2023 to 7 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 13 August 2026, reports an option exercise of €164k in Theralase Technologies Inc. The median gap between a trade and its publication by SEDI is 6 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations